Decoded: Why India’s $130 billion pharma ambition faces a hurdle as investigation backlogs delay drug batch releases
Summary
A Vector Consulting Group study finds that 80% of surveyed pharmaceutical manufacturing professionals reported batch-release delays due to open investigations, highlighting how incident backlogs, documentation requirements and supervisory constraints can affect factory productivity.
Description from Livemint.
Who is covering this
-
Decoded: Why India’s $130 billion pharma ambition faces a hurdle as investigation backlogs delay drug batch releases
A Vector Consulting Group study finds that 80% of surveyed pharmaceutical manufacturing professionals reported batch-release delays due to open investigations, highlighting how incident backlogs, documentation requirements and supervisory constraints can affect factory productivity.
Comments
Comments need JavaScript.